Cargando…

Interplay Between Gut Microbiota and Amino Acid Metabolism in Heart Failure

Heart failure (HF) is a complex clinical syndrome of which the incidence is on the rise worldwide. Cardiometabolic disorders are associated with the deterioration of cardiac function and progression of HF. Recently, there has been renewed interest in gut microbiota (GM) and its metabolites in the ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tuerhongjiang, Gulinigaer, Guo, Manyun, Qiao, Xiangrui, Lou, Bowen, Wang, Chen, Wu, Haoyu, Wu, Yue, Yuan, Zuyi, She, Jianqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566708/ https://www.ncbi.nlm.nih.gov/pubmed/34746265 http://dx.doi.org/10.3389/fcvm.2021.752241

Ejemplares similares

Circulating lipid and lipoprotein profiles and their correlation to cardiac function and cardiovascular outcomes in patients with acute myocardial infarction
por: Wu, Haoyu, et al.
Publicado: (2021)

HDL-C/apoA-I Ratio Is Associated with the Severity of Coronary Artery Stenosis in Diabetic Patients with Acute Coronary Syndrome
por: Sun, Lizhe, et al.
Publicado: (2021)

Cardiotoxicity Related to Immune Checkpoint Inhibitors: A Real-World Retrospective Analysis
por: She, Jianqing, et al.
Publicado: (2022)

ARNI versus ACEI/ARB in Reducing Cardiovascular Outcomes after Myocardial Infarction
por: She, Jianqing, et al.
Publicado: (2021)

Impact of Age, Sex, and Renal Function on the Efficacy and Safety of Direct Oral Anticoagulants vs. Vitamin K Antagonists for the Treatment of Acute Venous Thromboembolism: A Meta-Analysis of 22,040 Patients
por: Zhou, Bo, et al.
Publicado: (2021)

In-hospital initiation of PCSK9 inhibitor and short-term lipid control in patients with acute myocardial infarction
por: Lou, Bowen, et al.
Publicado: (2022)

Targeting amino acids metabolic profile to identify novel metabolic characteristics in atrial fibrillation
por: She, Jianqing, et al.
Publicado: (2018)

Association between Cystatin C and Cardiac Function in Acute Myocardial Infarction Patients: A Real-World Analysis
por: Lou, Bowen, et al.
Publicado: (2022)

Increased circulating uric acid aggravates heart failure via impaired fatty acid metabolism
por: Lou, Bowen, et al.
Publicado: (2023)

Uncovering the Role of Gut Microbiota in Amino Acid Metabolic Disturbances in Heart Failure Through Metagenomic Analysis
por: Hayashi, Tomohiro, et al.
Publicado: (2021)

The Interplay Between Gut Microbiota and miRNAs in Cardiovascular Diseases
por: Ionescu, Ruxandra Florentina, et al.
Publicado: (2022)

Alteration of the gut microbiota and metabolite phenylacetylglutamine in patients with severe chronic heart failure
por: Zhang, Zhendong, et al.
Publicado: (2023)

Glycoursodeoxycholic acid ameliorates diet-induced metabolic disorders with inhibiting endoplasmic reticulum stress
por: Cheng, Lele, et al.
Publicado: (2021)

Dysregulated Arginine Metabolism in Young Patients with Chronic Persistent Asthma and in Human Bronchial Epithelial Cells
por: Zhou, Bo, et al.
Publicado: (2021)

Role of the Gut Microbiota in Glucose Metabolism During Heart Failure
por: Bao, Pei, et al.
Publicado: (2022)

GSDME-mediated pyroptosis promotes the progression and associated inflammation of atherosclerosis
por: Wei, Yuanyuan, et al.
Publicado: (2023)

Clinical characteristics and protective factors in patients with acute myocardial infarction undergoing in-hospital myocardial free wall rupture: a single-center, retrospective analysis
por: Lou, Bowen, et al.
Publicado: (2019)

Gut Microbiota in Heart Failure Patients With Preserved Ejection Fraction (GUMPTION Study)
por: Huang, Ziyin, et al.
Publicado: (2022)

Knowledge Mapping of the Links Between the Gut Microbiota and Heart Failure: A Scientometric Investigation (2006–2021)
por: Mu, Fei, et al.
Publicado: (2022)

The Usefulness of C-Reactive Protein to Albumin Ratio in the Prediction of Adverse Cardiovascular Events in Coronary Chronic Total Occlusion Undergoing Percutaneous Coronary Intervention
por: Cheng, Lele, et al.
Publicado: (2021)

Serum lipids profiling perturbances in patients with ischemic heart disease and ischemic cardiomyopathy
por: Yang, Lin, et al.
Publicado: (2020)

Altered exosomal microRNA profiles in bronchoalveolar lavage fluid can mediate metabolism in patients with Acinetobacter baumannii ventilator-associated pneumonia
por: Zhou, Bo, et al.
Publicado: (2020)

Spermidine Affects Cardiac Function in Heart Failure Mice by Influencing the Gut Microbiota and Cardiac Galectin-3
por: Chen, Yufeng, et al.
Publicado: (2021)

Correlation of Triiodothyronine Level with In-Hospital Cardiac Function and Long-Term Prognosis in Patients with Acute Myocardial Infarction
por: She, Jianqing, et al.
Publicado: (2018)

Amino acid intake and plasma concentrations and their interplay with gut microbiota in vegans and omnivores in Germany
por: Dietrich, Stefan, et al.
Publicado: (2022)

Impact of depression and/or anxiety on patients with percutaneous coronary interventions after acute coronary syndrome: a protocol for a real-world prospective cohort study
por: Xiao, Yihui, et al.
Publicado: (2019)

Liuzijue training improves hypertension and modulates gut microbiota profile
por: Wu, Sha, et al.
Publicado: (2023)

Butterflies in the gut: the interplay between intestinal microbiota and stress
por: Lai, Tzu-Ting, et al.
Publicado: (2023)

Targeting erythropoietin protects against proteinuria in type 2 diabetic patients and in zebrafish
por: She, Jianqing, et al.
Publicado: (2017)

Targets of statins intervention in LDL-C metabolism: Gut microbiota
por: Sun, ChangXin, et al.
Publicado: (2022)

The Predictive Values of White Blood Cell Indices (Lymphocyte and Eosinophilic Granulocyte) for Heart Failure in Acute Coronary Syndrome Patients Following Percutaneous Coronary Intervention: A Prospective Cohort Study
por: Wen, Wen, et al.
Publicado: (2023)

Gut Microbiota and Atherosclerosis—Focusing on the Plaque Stability
por: Shen, Xinyi, et al.
Publicado: (2021)

The gut microbiota in experimental abdominal aortic aneurysm
por: Xiao, Jie, et al.
Publicado: (2023)

The interplay between oral microbiota, gut microbiota and systematic diseases
por: Tan, Xiujun, et al.
Publicado: (2023)

The interplay between the gut microbiota and the immune system
por: Geuking, Markus B, et al.
Publicado: (2014)

An overview on the interplay between nutraceuticals and gut microbiota
por: Catinean, Adrian, et al.
Publicado: (2018)

Polyphenols-gut microbiota interplay and brain neuromodulation
por: Filosa, Stefania, et al.
Publicado: (2018)

Interplay between gut microbiota and antimicrobial peptides
por: Zong, Xin, et al.
Publicado: (2020)

Interplay between Gut Lymphatic Vessels and Microbiota
por: Solari, Eleonora, et al.
Publicado: (2021)

The interplay between herbal medicines and gut microbiota in metabolic diseases
por: Wang, Lijie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1daoj15c1vq25ge7g6k4l4t5ok